Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 314561 - 314580 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lithuania | (L04AC07) tocilizumab (adm: P) | Tyenne 20 mg/ml koncentratas infuziniam tirpalui 10 ml N4 (4×1) (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania | (L04AC07) tocilizumab (adm: P) | Tyenne 20 mg/ml koncentratas infuziniam tirpalui 10 ml N4 (4×1) (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania | (L04AC07) tocilizumab (adm: P) | Tyenne 20 mg/ml koncentratas infuziniam tirpalui 4 ml N4 (4×1) (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml koncentratas infuziniam tirpalui 4 ml, N4 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH,Vokietija |
| Lithuania | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml koncentratas infuziniam tirpalui 4 ml, N4 (Roche Registration GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH,Vokietija |
| Lithuania | (L04AC07) tocilizumab (adm: P) | RoActemra 162 mg injekcinis tirpalas užpildytame švirkšte 0,9 ml N4 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH,Vokietija |
| Lithuania | (L04AC07) tocilizumab (adm: P) | Tyenne 162 mg injekcinis tirpalas užpildytame švirkšte N4 (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania | (L04AC07) tocilizumab (adm: P) | Tyenne 162 mg injekcinis tirpalas užpildytame švirkštiklyje N4 (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania | (L04AC08) canakinumab (adm: P) | Ilaris 150 mg/ml injekcinis tirpalas 1 ml N1 (Novartis Europharm Ltd., Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Cryopyrin-Associated Periodic Syndromes;Arthritis, Juvenile Rheumatoid;Arthritis, Gouty | NovartisEuropharmLtd.,Airija |
| Lithuania | (L04AC10) secukinumab (adm: P) | Cosentyx 150 mg injekcinis tirpalas užpildytame švirkštiklyje N1 (SensoReady) (Novartis Europharm Ltd., Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLtd.,Airija |
| Lithuania | (L04AC10) secukinumab (adm: P) | Cosentyx 150 mg injekcinis tirpalas užpildytame švirkštiklyje N1 (SensoReady) (Novartis Europharm Ltd., Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLtd.,Airija |
| Lithuania | (L04AC10) secukinumab (adm: P) | Cosentyx 150 mg injekcinis tirpalas užpildytame švirkštiklyje N2 (SensoReady) (Novartis Europharm Ltd., Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLtd.,Airija |
| Lithuania | (L04AC10) secukinumab (adm: P) | Cosentyx 300 mg injekcinis tirpalas užpildytame švirkštiklyje 2 ml N1 (Novartis Europharm Ltd., Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLtd.,Airija |
| Lithuania | (L04AC10) secukinumab (adm: P) | Cosentyx 300 mg injekcinis tirpalas užpildytame švirkštiklyje 2 ml N1 (Novartis Europharm Ltd., Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLtd.,Airija |
| Lithuania | (L04AC13) ixekizumab (adm: P) | Taltz 80 mg injekcinis tirpalas užpildytame švirkštiklyje 1 ml N1 (Eli Lilly and Company (Ireland) Limited, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | EliLillyandCompany[Ireland]Limited,Airija |
| Lithuania | (L04AC13) ixekizumab (adm: P) | Taltz 80 mg injekcinis tirpalas užpildytame švirkštiklyje 1 ml N3 (Eli Lilly and Company (Ireland) Limited, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | EliLillyandCompany[Ireland]Limited,Airija |
| Lithuania | (L04AC16) guselkumab (adm: P) | Tremfya 100 mg injekcinis tirpalas užpildytame švirkštiklyje 1 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L04AC16) guselkumab (adm: P) | Tremfya 100 mg injekcinis tirpalas užpildytame švirkštiklyje 1 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L04AC18) risankizumab (adm: P) | Skyrizi 150 mg injekcinis tirpalas užpildytame švirkštiklyje N1 (AbbVie Deutschland GmbH & Co. KG , Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic | AbbVieDeutschlandGmbH&Co.KG,Vokietija |
| Lithuania | (L04AC22) spesolimab (adm: P, course dose) | Spevigo 450 mg koncentratas infuziniam tirpalui 7,5 ml N2 (Boehringer Ingelheim International GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimInternationalGmbH,Vokietija |
Pages
